Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04310592
Title Natural Killer Cell (CYNK-001) Infusions in Adults With AML (CYNK001AML01)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celularity Incorporated
Indications

acute myeloid leukemia

Therapies

Cyclophosphamide + Fludarabine

CYNK-001

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.